References
Balkwill, F. (2009). Tumour necrosis factor and cancer. Nat Rev Cancer 9, 361–371.
Coley, W.B. (1891). Contribution to the knowledge of sarcoma. Ann Surg 14, 199–220.
Coley, W.B. (1910). The treatment of inoperable sarcoma by bacterial toxins (the mixed toxins of the Streptococcus erysipelas and the Bacillus prodigiosus). Proc R Soc Med 3, 1–48.
Chen, Z., Wen, D., and Gu, Z. (2020). Cargo-encapsulated cells for drug delivery. Sci China Life Sci 63, 599–601.
Chen, W., Wang, Y., Qin, M., Zhang, X., Zhang, Z., Sun, X., and Gu, Z. (2018). Bacteria-driven hypoxia targeting for combined biotherapy and photothermal therapy. ACS Nano 12, 5995–6005.
Chen, F., Zang, Z., Chen, Z., Cui, L., Chang, Z., Ma, A., Yin, T., Liang, R., Han, Y., Wu, Z., et al. (2019). Nanophotosensitizer-engineered Salmonella bacteria with hypoxia targeting and photothermal-assisted mutual bioaccumulation for solid tumor therapy. Biomaterials 214, 119226.
Gurbatri, C.R., Lia, I., Vincent, R., Coker, C., Castro, S., Treuting, P.M., Hinchliffe, T.E., Arpaia, N., and Danino, T. (2020). Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies. Sci Transl Med 12, eaax0876.
Fehleisen, F. (1883). Die etiologie des erysipels. Berlin: Theodor Fischer 16, 48.
Felfoul, O., Mohammadi, M., Taherkhani, S., de Lanauze, D., Zhong Xu, Y., Loghin, D., Essa, S., Jancik, S., Houle, D., Lafleur, M., et al. (2016). Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions. Nat Nanotech 11, 941–947.
Karbach, J., Neumann, A., Brand, K., Wahle, C., Siegel, E., Maeurer, M., Ritter, E., Tsuji, T., Gnjatic, S., Old, L.J., et al. (2012). Phase I clinical trial of mixed bacterial vaccine (Coley’s toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity. Clin Cancer Res 18, 5449–5459
Kort, E.N., Goy, M.F., Larsen, S.H., and Adler, J. (1975). Methylation of a membrane protein involved in bacterial chemotaxis. Proc Natl Acad Sci USA 72, 3939–3943.
Kim, J.E., Phan, T.X., Nguyen, V.H., Dinh-Vu, H.V., Zheng, J.H., Yun, M., Park, S.G., Hong, Y., Choy, H.E., Szardenings, M., et al. (2015). Salmonella typhimurium suppresses tumor growth via the pro-inflammatory cytokine interleukin-1β. Theranostics 5, 1328–1342.
Liu, L., He, H., Luo, Z., Zhou, H., Liang, R., Pan, H., Ma, Y., and Cai, L. (2020). In situ photocatalyzed oxygen generation with photosynthetic bacteria to enable robust immunogenic photodynamic therapy in triple-negative breast cancer. Adv Funct Mater 30, 1910176.
Nauts, H.C., Swif, W.E., and Coley, B.L. (1946). The treatment of malignant tumors by bacterial toxins as developed by the late William B. Coley, M.D., reviewed in the light of modern research. Cancer Res 6, 205–218.
Pawelek, J.M., Low, K.B., and Bermudes, D. (2003). Bacteria as tumour-targeting vectors. Lancet Oncol 4, 548–556.
Taherkhani, S., Mohammadi, M., Daoud, J., Martel, S., and Tabrizian, M. (2014). Covalent binding of nanoliposomes to the surface of magnetotactic bacteria for the synthesis of self-propelled therapeutic agents. ACS Nano 8, 5049–5060.
Wang, J., Wang, Y., Wang, R., Zhang, S., Liu, X., and Liang, X.J. (2019). Targeted nanoparticles for precise cancer therapy. Sci China Life Sci 62, 1392–1395.
Zheng, P., Fan, M., Liu, H., Zhang, Y., Dai, X., Li, H., Zhou, X., Hu, S., Yang, X., Jin, Y., et al. (2021). Self-propelled and near-infrared-phototaxic photosynthetic bacteria as photothermal agents for hypoxiatargeted cancer therapy. ACS Nano 15, 1100–1110.
Zhang, Y., Liu, H., Dai, X., Li, H., Zhou, X., Chen, S., Zhang, J., Liang, X. J., and Li, Z. (2021). Cyanobacteria-based near-infrared light-excited self-supplying oxygen system for enhanced photodynamic therapy of hypoxic tumors. Nano Res 14, 667–673.
Zheng, D.W., Chen, Y., Li, Z.H., Xu, L., Li, C.X., Li, B., Fan, J.X., Cheng, S.X., and Zhang, X.Z. (2018). Optically-controlled bacterial metabolite for cancer therapy. Nat Commun 9, 1680.
Zheng, J.H., Nguyen, V.H., Jiang, S.N., Park, S.H., Tan, W., Hong, S.H., Shin, M.G., Chung, I.J., Hong, Y., Bom, H.S., et al. (2017). Two-step enhanced cancer immunotherapy with engineered Salmonella typhimurium secreting heterologous flagellin. Sci Transl Med 9, eaak9537.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (31971304), Science Fund for Creative Research Groups of Natural Science Foundation of Hebei Province (B2021201038), the Beijing-Tianjin-Hebei Basic Research Cooperation Project (19JCZDJC64100), and Doctoral Students Innovation Project of Hebei Province (CXZZBS2020022, CXZZBS2021011).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Compliance and ethics The author(s) declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Han, Y., Fan, M., Han, D. et al. Bacteria-based nanosystems for enhanced antitumor therapy. Sci. China Life Sci. 65, 438–441 (2022). https://doi.org/10.1007/s11427-021-1991-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-021-1991-y